Beta-cell mitochondria in the regulation of insulin secretion: A new culprit in Type II diabetes

Diabetologia

Volumn 43, Issue 3, 2000, Pages 265-277

  Wollheim, C B ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

ATP; Beta cell dysfunction; Cytosolic Ca2+; Exocytosis; HNF 1 ; Mitochondrial Ca2+; Mitochondrial DNA; Mitochondrial metabolism; MODY; cells

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCIUM ION; GLUCOSE; INSULIN; MITOCHONDRIAL DNA; OXIDOREDUCTASE;

CALCIUM TRANSPORT; CITRIC ACID CYCLE; DIABETOGENESIS; ENZYME ACTIVATION; EXOCYTOSIS; GLUCOSE BLOOD LEVEL; HUMAN; HYPERPOLARIZATION; INSULIN RELEASE; MATURITY ONSET DIABETES MELLITUS; MEMBRANE DEPOLARIZATION; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; MUTATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS CELL; PRIORITY JOURNAL; RESPIRATORY CHAIN; REVIEW;

EID: 0034064334     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250050044     Document Type: Review

References (87)

1. 1. Renold AE, Rabinovitch A, Wollheim CB et al. (1974) Spontaneous and experimental diabetic syndromes in animals. A re-evaluation of their usefulness for approaching the physio-pathology of diabetes. (Claude Bernard Lecture 1973) In: WJ Malaisse, J Pirart (eds) Diabetes. Excerpta Medica Internat. Congress Series 312: 22-38, Amsterdam
2. 2. Bernard C (1859) Leçons sur les propriétés physiologiques et les altérations pathologiques des liquides de l'organisme. J.B. Balliere et fils, Paris
3. 3. Bernard C (1849) Du suc pancréatique et de son rôle dans les phénomènes de la digestion. Mémoires de la Société de Biologie 1: 99-115
4. 4. Orci L (1974) A portrait of the pancreatic β-cell (Minkowski Lecture 1973). Diabetologia 10: 163-187
5. 2+ and G-proteins. Diabetes Rev 4: 276-297
6. 6. Lang J (1999) Molecular mechanisms and regulation of insulin exocytosis as a paradigm of endocrine secretion. Eur J Biochem 259: 3-17
7. 7. Sharp GWG (1996) Mechanisms of inhibition of insulin release. Am J Physiol 271: C1781-C1799
8. 8. Rorsman P (1997) The pancreatic beta-cell as a fuel sensor: an electrophysiologist's viewpoint (Minkowski Lecture 1996). Diabetologia 40: 487-495
9. 9. Bock JB, Scheller RH (1999) SNARE proteins mediate lipid bilayer fusion. Proc Natl Acad Sci USA 96: 12227-12229
10. 10. Voet D, Voet JG (1995) Biochemistry, 2nd edn. John Wiley & Sons, New York
11. 11. Cerasi E (1975) Mechanisms of glucose stimulated insulin secretion in health and in diabetes: some re-evaluations and proposals (Minkowski Lecture 1974). Diabetologia 11: 1-13
12. 12. Porte D Jr (1991) β-cells in type II diabetes mellitus (Banting Lecture 1990). Diabetes 40: 166-180
13. 13. Hosker JP, Rudenski AS, Burnett MA, Matthews DR, Turner RC (1989) Similar reduction of first-and second-phase β-cell responses at three different glucose levels in type II diabetes and the effect of gliclazide therapy. Metabolism 38: 767-772
14. 14. DeFronzo RA (1997) Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes. Diabetes Rev 5: 177-269
15. 15. Vaag A, Henriksen JE, Madsbad S, Holm N, Beck-Nielsen H (1995) Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus. J Clin Invest 95: 690-698
16. 16. Pimenta W, Korytkowski M, Mitrakou A et al. (1995) Pancreatic β-cell dysfunction as the primary genetic lesion in NIDDM. JAMA 273: 1855-1861
17. 17. Newgard CB, McGarry JD (1995) Metabolic coupling factors in pancreatic β-cell signal transduction. Annu Rev Biochem 64: 689-719
18. 18. Matschinsky FM (1996) A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm (Banting Lecture 1995). Diabetes 45: 223-241
19. 19. De Vos A, Heimberg H, Quartier E et al. (1995) Human and rat beta cells differ in glucose transporter but not in glucokinase gene expression. J Clin Invest 96: 2489-2495
20. 20. Iynedjian PB (1993) Mammalian glucokinase and its gene. Biochem J 293: 1-13
21. 21. Froguel P, Zouali H, Vionnet N at al. (1993) Familial hyperglycemia due to mutations in glucokinase: definition of a subtype of diabetes mellitus. N Engl J Med 328: 697-702
22. 22. Schuit F, De Vos A, Farfari S (1997) Metabolic fate of glucose in purified islet cells. J Biol Chem 272: 18572-18579
23. 23. Sekine N, Cirulli V, Regazzi R et al. (1994) Low lactate dehydrogenase and high mitochondrial glycerol phosphate dehydrogenase in pancreatic β-cell. Potential role in nutrient sensing. J Biol Chem 269: 4895-4902
24. 24. Ishihara H, Wang H, Drewes LR, Wollheim CB (1999) Overexpression of monocarboxylate transporter and lactate dehydrogenase alters insulin secretory responses to pyruvate and lactate in β cells. J Clin Invest 104: 1621-1629
25. 25. Maechler P, Wang H, Wollheim CB (1998) Continuous monitoring of ATP levels in living insulin secreting cells expressing cytosolic firefly luciferase. FEBS Lett 422: 328-332
26. 26. Kennedy ED, Maechler P, Wollheim CB (1998) Effects of depletion of mitochondrial DNA on metabolism-secretion coupling in INS-1 cells. Diabetes 47: 374-380
27. 27. Eto K, Tsubamoto Y, Terauchi Y et al. (1999) Role of NADH shuttling system in glucose-induced activation of mitochondrial metabolism and insulin secretion. Science 283: 981-985
28. 28. Wollheim CB, Sharp GW (1981) Regulation of insulin release by calcium. Physiol Rev 61: 914-973
29. 2+ and secretion. EMBO J 9: 53-60
30. 30. Duchen MR, Smith PA, Ashcroft FM (1993) Substrate-dependent changes in mitochondrial function, intracellular free calcium concentration and membrane channels in pancreatic β-cells. Biochem J 294: 35-42
31. 2+ transients. J Biol Chem 269: 27310-27314
32. 32. Maechler P, Kennedy ED, Pozzan T, Wollheim CB (1997) Mitochondrial activation directly triggers the exocytosis of insulin in permeabilized pancreatic β-cells. EMBO J 16: 3833-3841
33. 33. Detimary P, Dejonghe S, Ling Z, Pipeleers D, Schult F, Henquin J-C (1998) The changes in adenine nucleotides measured in glucose-stimulated rodent islets occur in β-cells but not in α cells and are also observed in human islets. J Biol Chem 273: 33905-33908
34. 34. Cook DL, Hales CN (1984) Intracellular ATP directly blocks K channels in pancreatic β-cells. Nature 211: 269-271
35. 35. Ashcroft FM, Harrison DE, Ashcroft SJH (1984) Glucose induces closure of single potassium channels in isolated rat pancreatic β-cells. Nature 312: 446-448
36. 36. Dean PM, Matthews EK (1968) Electrical activity in pancreatic islet cells. Nature 219: 389-390
37. 37. Horváth A, Szabadkai G, Vámai P et al. (1998) Voltage dependent calcium channels in adrenal glomerulosa cells and in insulin producing cells. Cell Calcium 23: 33-42
38. 38. Ligon B, Boyd AE 3rd, Dunlap K (1998) Class A calcium channel variants in pancreatic islets and their role in insulin secretion. J Biol Chem 273: 13905-13911
39. 39. Rorsman P (1997) The pancreatic beta-cell as a fuel sensor: an electrophysiologist's viewpoint (Minkowski Lecture 1996). Diabetologia 40: 487-495
40. 40. McCormack JG, Halestrap AP, Denton RM (1990) Role of calcium ions in regulation of mammalian intramitochondrial metabolism. Physiol Rev 70: 391-425
41. 41. Prentki M (1996) New insights into pancreatic beta-cell metabolic signaling in insulin secretion. Eur J Endocrinol 134: 272-286
42. 42. Bratusch-Marrain P, Ferenci P, Waldhäusl W (1980) Leucine assimilation in patients with diabetes mellitus. Acta Endocrinol 93: 461-465
43. 43. Smith PA, Sakura H, Coles B, Gummerson N, Proks P, Ashcroft FM (1997) Electrogenic arginine transport mediates stimulus-secretion coupling in mouse pancreatic β-cells. J Physiol 499: 625-635
44. KATP: an inward rectifier subunit plus the sulfonylurea receptor. Science 270: 1166-1170
45. 2+ balance as a determinant for glucose-stimulated insulin release. Diabetologia 28: 494-501
46. 46. Malaisse WJ (1996) Metabolic signaling of insulin secretion. Diabetes Rev 4: 145-159
47. 47. Asfari M, Janjic D, Meda P, Li G, Halban PA, Wollheim CB (1992) Establishment of 2-mercaptoethanol dependent differentiated insulin secreting cell lines. Endocrinology 130: 167-178
48. 2+ in aequorin expressing INS-1 cells. J Clin Invest 98: 2524-2538
49. 49. Kennedy ED, Wollheim CB (1998) Role of mitochondrial calcium in metabolism-secretion coupling in nutrient-stimulated insulin release. Diabetes Metab 24: 15-24
50. + channels in mouse β-cells. J Clin Invest 89: 1288-1295
51. 51. Henquin JC, Gembal M, Detimary P, Gao ZY, Warnotte C, Gilon P (1994) Multisite control of insulin release by glucose. Diabète Metab 20: 132-137
52. 2+ influx in rat pancreatic β-cell. Diabetes 41: 438-443
53. 2+ in cells and tissues. J Bioenerg Biomembr 23: 823-854
54. 2+-sensitive 2-ketoglutarate dehydrogenase in the regulation of mitochondrial function. Biochim Biophys Acta 1019: 42-50
55. 2+, substrate and ADP. Biochem J 318: 615-621
56. 2+ and insulin secretion responses in the β-cell. J Biol Chem 273: 20770-20778
57. 57. Maechler P, Wollheim CB (1999) Mitochondrial glutamate acts as a messenger in glucose-induced insulin exocytosis. Nature 402: 685-689
58. 58. Rötig A, Bonnefont J-P, Munnich A (1996) Mitochondrial diabetes mellitus. Diabetes Metab 22: 291-298
59. 59. Wallace DC (1992) Diseases of the mitochondrial DNA. Annu Rev Biochem 61: 1175-1212
60. 60. Johns DR (1995) Mitochondrial DNA and disease. N Engl J Med 333: 638-644
61. 61. Sherratt EJ, Thomas AW, Alcolado JC (1997) Mitochondrial DNA defects: a widening clinical spectrum of disorders. Clin Sci 92: 225-235
62. 62. Ernster L, Ikkos D, Luft R (1959) Enzymic activities of human skeletal muscle mitochondria: a tool in clinical metabolic research. Nature 184: 1851-1854
63. 63. Luft R, Ikkos D, Palmieri G, Ernster L, Afzelius B (1962) A case of severe hypermetabolism of nonthyroid origin with a defect in the maintenance of mitochondrial respiratory control: a correlated clinical, biochemical and morphological study. J Clin Invest 41: 1776-1804
64. 64. Ballinger SW, Shoffner JM, Hedaya EV et al. (1992) Maternally transmitted diabetes and deafness associated with a 10.4 kb mitochondrial DNA deletion. Nat Genet 1: 11-15
65. Leu(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nat Genet 1: 368-371
66. 66. Gerbitz K-D, Van den Ouweland JMW, Maassen JA, Jaksch M (1995) Mitochondrial diabetes mellitus: a review. Biochim Biophys Acta 1271: 253-260
67. Leu(UUR) mutation in mitochondrial DNA derived from patients with maternally inherited diabetes and deafness (MIDD) and progressive kidney disease. Diabetologia 42: 485-492
68. 68. Kobayashi T, Nakanishi K, Nakase H et al. (1997) In situ characterization of islets in diabetes with a mitochondrial DNA mutation at nucleotide position 3243. Diabetes 46: 1567-1671
69. 69. King MP, Attardi G (1989) Human cells lacking mtDNA repopulation with exogenous mitochondria by complementation. Science 246: 500-503
70. 70. Soejima A, Inoue K, Takai D et al. (1996) Mitochondrial DNA is required for regulation of glucose-stimulated insulin secretion in a mouse pancreatic β-cell line MIN6. J Biol Chem 271: 26194-26199
71. 71. Tattersall RB, Fajans SS (1975) A difference between the inheritance of classical juvenile-onset and maturity-onset type diabetes of young people. Diabetes 24: 44-53
72. 72. Fajans SS, Bell GI, Bowden DW, Halter JB, Polonsky KS (1994) Maturity-onset diabetes of the young. Life Sci 55: 413-422
73. 73. Froguel Ph, Vaxillaire M, Sun F et al. (1992) Close linkage of glucokinase locus on chromosome 7 p to early-onset non-insulin-dependent diabetes mellitus. Nature 356: 162-164
74. 74. Yamagata K, Furuta H, Oda N et al. (1996) Mutations in the hepatocyte nuclear factor-4α gene in maturity-onset diabetes of the young. Nature 384: 458-460
75. 75. Yamagata K, Oda N, Kaisaki PJ et al. (1996) Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young. Nature 384: 455-458
76. 76. Stoffers DA, Ferre J, Clarke WL, Habener JF (1997) Early-onset type-II diabetes mellitus (MODY 4) linked to IPF-1. Nat Genet 17: 138-139
77. 77. Macfarlane WM, Frayling TM, Ellard S et al. (1999) Missense mutations in the insulin promoter factor-1 gene predispose to type 2 diabetes. J Clin Invest 104: R33-R39
78. 78. Hani EH, Stoffers DA, Chèvre J-C et al. (1999) Defective mutations in the insulin promoter factor-1 (IPF-1) gene in late-onset type 2 diabetes mellitus. J Clin Invest 104: R41-R48
79. 79. Lindner T, Yamagata K, Ogata M et al. (1997) Mutation in hepatocyte nuclear factor-1β gene (TCF2) associated with MODY. Nat Genet 17: 384-385
80. 80. Malecki MT, Jhala US, Antonellis A et al. (1999) Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus. Nat Genet 23: 323-328
81. 81. Hattersley AT (1998) Maturity-onset diabetes of the young: clinical heterogeneity explained by genetic heterogeneity. Diabet Med 15: 15-24
82. 82. Velho G, Froguel Ph (1998) Genetic, metabolic and clinical characteristics of maturity onset diabetes of the young. Eur J Endocrinol 138: 233-239
83. 83. Byrne MM, Sturis J, Menzel S et al. (1996) Altered insulin secretory responses to glucose in diabetic and nondiabetic subjects with mutations in the diabetes susceptibility gene MODY3 on chromosome 12. Diabetes 45: 1503-1510
84. 84. Nicosia A, Monaci P, Tomei L et al. (1990) A myosin-like dimerization helix and an extra-large homeodomain are essential elements of the tripartite DNA binding structure of LFB1. Cell 6: 1225-1236
85. 85. Wang H, Maechler P, Hagenfeldt KA, Wollheim CB (1998) Dominant-negative suppression of HNF-1α function results in defective insulin gene transcription and impaired metabolism-secretion coupling in a pancreatic β-cell line. EMBO J 17: 6701-6713
86. 86. Pontoglio M, Sreenan S, Roe M et al. (1998) Defective insulin secretion in hepatocyte factor 1α-deficient mice. J Clin Invest 101: 2215-2222
87. 87. Stanley CA, Lieu YK, Hsu BY et al. (1998) Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene. N Engl J Med 338: 1352-1357